This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Smoking and valproate

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • nicotine, the main addictive chemical in tobacco smoke, is essential to continued and compulsive tobacco use
    • when inhaled, nicotine is rapidly delivered to the systemic circulation
      • once nicotine is in the bloodstream then it is distributed extensively to body tissues
    • plasma half life of nicotine averages about 2 hours
      • the vast majority of nicotine is metabolized in the liver by the cytochrome P450 enzyme CYP2A6 (70-80%)
        • nicotine is metabolized to cotinine, and cotinine is further metabolized to 3'-hydroxycotinine (3HC) primarily by the liver enzyme CYP2A6
          • also, there is lesser metabolism of nicotine by other oxidative (CYP2B6 and CYP2D6) and non-oxidative pathways
        • CYP2A6 is genetically polymorphic, individuals carrying inactive CYP2A6 alleles have decreased nicotine metabolism, are less likely to become smokers and if they do, they smoke fewer cigarettes per day
  • oral contraceptive medications is known to increase nicotine metabolism at CYP2A6

  • in a study comparing the effects of valproate and carbamazepine on CYP2A6 actvity in patients with mental illness
    • it was shown that carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness (3)

  • it is theorised that smokers with rapid nicotine metabolism might be expected to smoke more intensely to compensate for the more rapid disappearance of nicotine from the blood and brain, and may have more difficulty in quitting smoking

Referernce:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.